Latest Articles
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Nigeria
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Nigeria
Published: Jan. 24, 2026, 5:45 a.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress By Investing.com - Investing.com India
Acrivon to present ACR-368 endometrial cancer data at ESGO congress By Investing.com Investing.com India
Published: Jan. 24, 2026, 4:02 a.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Canada
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Canada
Published: Jan. 23, 2026, 10:24 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Australia
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Australia
Published: Jan. 23, 2026, 3:48 p.m.
Ibuprofen may decrease cancer risk - Female First
Ibuprofen may decrease cancer risk Female First
Published: Jan. 23, 2026, 3:16 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com
Published: Jan. 23, 2026, 2:07 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com UK
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com UK
Published: Jan. 23, 2026, 1:18 p.m.
Effect of Astragalus sinicus Ethanol Extract on Menopausal Symptoms in an Ovariectomized (OVX) Mouse Model.
As the aging population grows, the proportion of postmenopausal women is also increasing. Menopause can cause various symptoms and reduce quality of life. Hormone replacement therapy (HRT) is a common …
Published: Jan. 23, 2026, midnight
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Link copied to clipboard!